NeoProteomics Licenses Technology from Case Western Reserve University

The agreement covers tools and biomarkers "that will permit the company to expand its portfolio" in personalized medicine.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories